A study by Smolen et al. showed that TNF-α blockers had a beneficial effect on inflammatory disease activity and joint degradation, achieving high rates of sustained clinical remission by preventing radiographic damage in RA [64]. Here, TNF is linked to rheumatoid arthritis.